To equip women’s healthcare providers with advanced AI medical device technologies for the detection of cervical cancer
Cervical cancer is the fourth most common cancer affecting women globally and the second most common cancer for women in low resource settings.
Lack of infrastructure, low availability of resources, together with a shortage of trained medical staff have led to limited access to cervical cancer screening and treatment.
Improving access to expert care with the EVA System.
Our Enhanced Visual Assessment (EVA) System is an FDA cleared and CE marked mobile colposcope used to visualize the cervix. With high-quality optics, secure image and video capture, and online data management system, EVA drastically improves accessibility to expert care with its telemedicine and AI clinical decision support capabilities.